Market niche Pharmaceutical manufacturing focus with a localized New City, NY presence presents a target for regional pharmaceutical supply chain services, contract manufacturing capabilities, and regulatory compliance consulting tailored to mid-sized U.S. pharma players.

Tech enablement Adoption of multiple cloud and web security platforms (AWS, Azure, Cloudflare, Cloudflare Bot Management) and front-end tech (React) indicates potential for offering cloud migration, cybersecurity hardening, data integrity, and managed hosted solutions for compliance-heavy pharmaceutical workflows.

Low footprint Very small team (0-1 employees) suggests outsourcing needs for business development, admin, regulatory affairs, quality assurance, and GMP compliance, presenting opportunities for outsourcing partnerships, interim leadership, or SDR-led deal acceleration.

Competitive landscape Compared to large consulting peers, Mjac’s size signals a potential entry point for scalable, cost-efficient advisory services, including digital transformation, process optimization, and niche regulatory consulting for pharma manufacturing segments.

Expansion potential Absence of funding information paired with a basic online footprint implies opportunities to upsell services in fundraising advisory, grant/financing support for pharma tech implementations, and market entry strategies to broaden regional and digital capabilities.